Ozempic
About
What does Ozempic do?
Ozempic is a brand-name prescription medication containing the active ingredient semaglutide, developed and manufactured by the pharmaceutical company Novo Nordisk. It is indicated for the treatment of type 2 diabetes and for reducing the risk of major cardiovascular events, and is widely recognized for its off-label and approved use in weight management.
Where is Ozempic headquartered?
Ozempic is headquartered in Bagsværd, Denmark.
What industry does Ozempic operate in?
Ozempic operates in Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
Longevity and metabolic health platform offering personalized insights and interventions.
AI-powered platform for personalized health and longevity.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.